For a limited time, Wegovy will be available to new patients at $199 for the first month, Novo Nordisk said Thursday.

Inadequate supply has created opportunities for bad actors seeking to profit from shortages, high costs and demand ...

Widely used GLP-1 drugs for type 2 diabetes such as Novo Nordisk's Ozempic may modestly reduce the risk of obesity-related ...

Starting today, pharmacies can no longer make cheaper alternatives to popular weight loss drugs, driving up costs for ...

News last week that a CNN investigative report found dozens of fake podcasts on the popular audio streaming and media service platform Spotify, illegally ...

But the FDA declared months ago that the shortages of semaglutide and tirzepatide injections had ended, effectively ending flexibilities for compounded products. The grace period for manufacturers to ...

Online weight-loss company Noom has begun offering smaller doses of compounded versions of Novo Nordisk's Wegovy as the U.S.

Compounding pharmacies are supposed to stop producing the compounded versions of the popular weight loss medications now that ...

Global pharmaceutical giant Eli Lilly & Co. is seeking tax incentives for a potential 236-acre biomanufacturing plant in ...

Jamie Dimon's Would-Be Successors Audition for the Top Job at JPMorgan Investors will gather in midtown Manhattan to see who might become the bank's next CEO. Trump Attacks Walmart for Tariff-Related ...

Providers of compounded obesity drugs are finding—for now—a new way into the booming market by tweaking formulations.